Eton Pharmaceuticals Inc (ETON)
3.64
+0.02
(+0.55%)
USD |
NASDAQ |
May 20, 16:00
3.64
0.00 (0.00%)
After-Hours: 20:00
Eton Pharmaceuticals Market Cap: 93.51M for May 20, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 20, 2024 | 93.51M |
| May 17, 2024 | 93.00M |
| May 16, 2024 | 93.77M |
| May 15, 2024 | 93.77M |
| May 14, 2024 | 93.26M |
| May 13, 2024 | 91.20M |
| May 10, 2024 | 88.12M |
| May 09, 2024 | 88.25M |
| May 08, 2024 | 95.57M |
| May 07, 2024 | 95.57M |
| May 06, 2024 | 96.34M |
| May 03, 2024 | 95.31M |
| May 02, 2024 | 96.34M |
| May 01, 2024 | 94.53M |
| April 30, 2024 | 89.91M |
| April 29, 2024 | 90.42M |
| April 26, 2024 | 88.62M |
| April 25, 2024 | 80.15M |
| April 24, 2024 | 82.46M |
| April 23, 2024 | 84.26M |
| April 22, 2024 | 83.49M |
| April 19, 2024 | 81.94M |
| April 18, 2024 | 78.61M |
| April 17, 2024 | 80.66M |
| April 16, 2024 | 81.94M |
| Date | Value |
|---|---|
| April 15, 2024 | 82.72M |
| April 12, 2024 | 87.85M |
| April 11, 2024 | 88.38M |
| April 10, 2024 | 88.12M |
| April 09, 2024 | 91.72M |
| April 08, 2024 | 88.63M |
| April 05, 2024 | 92.23M |
| April 04, 2024 | 91.46M |
| April 03, 2024 | 92.49M |
| April 02, 2024 | 94.54M |
| April 01, 2024 | 96.34M |
| March 28, 2024 | 96.33M |
| March 27, 2024 | 97.61M |
| March 26, 2024 | 97.87M |
| March 25, 2024 | 99.67M |
| March 22, 2024 | 101.72M |
| March 21, 2024 | 92.99M |
| March 20, 2024 | 89.91M |
| March 19, 2024 | 90.94M |
| March 18, 2024 | 89.39M |
| March 15, 2024 | 98.90M |
| March 14, 2024 | 114.57M |
| March 13, 2024 | 115.08M |
| March 12, 2024 | 113.03M |
| March 11, 2024 | 117.14M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
51.10M
Minimum
Oct 20 2022
244.83M
Maximum
Feb 17 2021
115.54M
Average
106.84M
Median
Nov 04 2019
Market Cap Benchmarks
| Eli Lilly and Co | 744.34B |
| Evoke Pharma Inc | 4.040M |
| Outlook Therapeutics Inc | 186.07M |
| NovaBay Pharmaceuticals Inc | 6.598M |
| Palatin Technologies Inc | 32.92M |
Market Cap Related Metrics
| PE Ratio | 91.00 |
| PS Ratio | 2.738 |
| Price to Book Value | 6.036 |
| Price to Free Cash Flow | 23.43 |
| Price | 3.64 |
| Earnings Yield | 1.10% |
| Operating PE Ratio | 173.28 |
| Normalized PE Ratio | 91.00 |